How should chronic medical therapies be altered with the onset of end-stage renal disease and initiation of dialysis?

Semin Dial. 2006 Jan-Feb;19(1):8-24. doi: 10.1111/j.1525-139X.2006.00106.x.

Authors

Kathleen L Wyne¹, Steven Fishbane, Geoffrey A Block, Karen Warburton, Jeffrey S Berns, Alicia M Neu, Bradley A Warady

Affiliation

¹ Division of Endocrinology and Metabolism, Department of Internal Medicine, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75390-8857, USA. [email protected]

PMID: 16423174
DOI: 10.1111/j.1525-139X.2006.00106.x

No abstract available

Publication types

Review

MeSH terms

Chronic Disease
Diabetic Nephropathies / therapy
Disease Progression
Dyslipidemias / complications
Dyslipidemias / drug therapy
Humans
Kidney Diseases / complications
Kidney Diseases / therapy*
Kidney Failure, Chronic / complications
Kidney Failure, Chronic / therapy*
Renal Dialysis*